{"hands_on_practices": [{"introduction": "The behavior of biological systems is often governed by the logic of underlying gene regulatory networks. This exercise introduces Boolean networks, a powerful way to model this logic and understand how simple interactions can lead to complex dynamic behaviors. By analyzing a classic negative feedback loop, you will discover how such a network motif can generate sustained oscillations, a fundamental pattern in both healthy and diseased cells [@problem_id:1469992].", "id": "1469992", "problem": "In systems biology, simple gene regulatory networks can be modeled using a Boolean framework to understand their dynamic behaviors. Consider a simplified two-gene system involving Gene A and Gene B. The state of each gene can be either 'ON' (represented by 1) or 'OFF' (represented by 0). The state of the entire system at any discrete time step $t$ is given by the pair of values $(A(t), B(t))$.\n\nThe regulatory interactions are as follows:\n1.  Gene A activates Gene B. This means Gene B will be 'ON' at the next time step, $t+1$, if and only if Gene A is 'ON' at the current time step $t$.\n2.  Gene B represses Gene A. This means Gene A will be 'ON' at the next time step, $t+1$, if and only if Gene B is 'OFF' at the current time step $t$.\n\nThe system updates its state synchronously, meaning the states of both Gene A and Gene B at time $t+1$ are determined simultaneously based on the system's state at time $t$.\n\nA \"steady state\" is a state $(A, B)$ that does not change over time. A \"limit cycle\" is a sequence of states that the system repeates periodically. A steady state or a limit cycle is referred to as an \"attractor\" of the system, representing its long-term behavior.\n\nBased on the rules provided, identify the attractor(s) of this two-gene system.\n\nA. The system has two steady states: (0, 1) and (1, 0).\nB. The system has one steady state: (0, 0).\nC. The system has a single limit cycle involving the states (0, 0), (1, 0), (1, 1), and (0, 1).\nD. The system has two separate limit cycles: one involving (0, 0) and (1, 0), and another involving (0, 1) and (1, 1).\nE. The system has two steady states: (0, 0) and (1, 1).\n\n", "solution": "Let the state at time $t$ be $(A(t), B(t))$ with $A(t), B(t) \\in \\{0,1\\}$. By the given regulatory rules and synchronous update:\n- Gene A is ON at $t+1$ if and only if Gene B is OFF at $t$, hence\n$$\nA(t+1) = 1 - B(t).\n$$\n- Gene B is ON at $t+1$ if and only if Gene A is ON at $t$, hence\n$$\nB(t+1) = A(t).\n$$\n\nFirst, determine steady states by solving for $(A,B)$ such that $(A,B)$ equals its update:\n$$\n\\begin{cases}\nA = 1 - B, \\\\\nB = A.\n\\end{cases}\n$$\nSubstituting $B = A$ into the first equation gives\n$$\nA = 1 - A \\;\\Rightarrow\\; 2A = 1 \\;\\Rightarrow\\; A = \\frac{1}{2}.\n$$\nSince $A \\in \\{0,1\\}$, there is no solution; hence, there are no steady states.\n\nNext, compute the synchronous updates for all four possible states:\n- If $(A,B) = (0,0)$, then\n$$\nA' = 1 - 0 = 1,\\quad B' = 0 \\;\\Rightarrow\\; (A',B') = (1,0).\n$$\n- If $(A,B) = (1,0)$, then\n$$\nA' = 1 - 0 = 1,\\quad B' = 1 \\;\\Rightarrow\\; (A',B') = (1,1).\n$$\n- If $(A,B) = (1,1)$, then\n$$\nA' = 1 - 1 = 0,\\quad B' = 1 \\;\\Rightarrow\\; (A',B') = (0,1).\n$$\n- If $(A,B) = (0,1)$, then\n$$\nA' = 1 - 1 = 0,\\quad B' = 0 \\;\\Rightarrow\\; (A',B') = (0,0).\n$$\n\nThus the system evolves through the cycle\n$$\n(0,0) \\rightarrow (1,0) \\rightarrow (1,1) \\rightarrow (0,1) \\rightarrow (0,0),\n$$\nwhich is a limit cycle of length $4$. Since all four states lie on this cycle, it is the unique attractor of the system. Therefore, the correct choice is the single limit cycle described in option C.", "answer": "$$\\boxed{C}$$"}, {"introduction": "Beyond the logic of individual circuits, we can model the progression of a disease at the whole-organism level using quantitative frameworks. This practice uses a simplified differential equation model to describe the battle between a virus and the immune system. Your task is to interpret the model's parameters, a crucial skill for connecting abstract mathematical representations to tangible biological processes like viral replication [@problem_id:1469993].", "id": "1469993", "problem": "In a simplified model of an acute viral infection within a host, the dynamics of the viral load, $V(t)$, can be described by a differential equation. Let $V(t)$ represent the concentration of virus particles in the blood at time $t$, and let $I(t)$ represent the concentration of activated immune cells (e.g., cytotoxic T-lymphocytes) that target the virus.\n\nA basic model for the rate of change of the viral load is given by:\n$$\n\\frac{dV}{dt} = pV - cVI\n$$\n\nHere, $p$ and $c$ are positive constant parameters. The term $pV$ represents the production of new virus particles, while the term $cVI$ represents the clearance of the virus by the immune system.\n\nBased on this model, which of the following statements provides the most accurate biological interpretation of the parameter $p$?\n\nA. The rate at which new immune cells are produced in response to the infection.\nB. The efficiency of the immune system in neutralizing one unit of viral load per unit of immune cell concentration.\nC. The rate at which an individual immune cell can clear virus particles.\nD. The intrinsic net growth rate of the virus in the absence of the adaptive immune response modeled.\nE. The total number of virus particles that can be sustained by the host.\n\n", "solution": "We are given the within-host viral dynamics\n$$\n\\frac{dV}{dt} = pV - cVI,\n$$\nwhere $V(t)$ is viral load and $I(t)$ is the concentration of activated immune cells. The term $pV$ represents per-capita viral production and $cVI$ represents immune-mediated clearance under mass-action interaction.\n\nTo interpret $p$, consider the system in the absence of the adaptive immune response, which in this model corresponds to setting $I(t)=0$. Then the equation reduces to\n$$\n\\frac{dV}{dt} = pV.\n$$\nSolving by separation of variables,\n$$\n\\frac{dV}{V} = p\\,dt \\quad \\Rightarrow \\quad \\ln V = pt + C \\quad \\Rightarrow \\quad V(t) = V(0)\\exp(pt).\n$$\nThis solution shows that $p$ is the exponential growth rate (per-capita net growth rate) of the virus when immune-mediated clearance is absent. Therefore, $p$ is the intrinsic net growth rate of the virus in the absence of the adaptive immune response term $cVI$. Its units are inverse time, consistent with an exponential growth parameter.\n\nFor completeness, note that $c$ multiplies the interaction term $VI$ and thus quantifies the efficiency of immune-mediated clearance per immune cell per unit viral load (a mass-action coefficient), which aligns with option B or C descriptions for $c$, not $p$.\n\nEvaluating the options:\n- A is incorrect because it refers to immune cell production, not viral growth.\n- B and C describe the clearance efficiency parameter $c$, not $p$.\n- D correctly identifies $p$ as the intrinsic net growth rate of the virus absent the adaptive immune response.\n- E is incorrect because it refers to a carrying capacity, which does not appear in this linear model.\n\nThus, the most accurate interpretation is D.", "answer": "$$\\boxed{D}$$"}, {"introduction": "A central goal in systems medicine is to identify reliable biomarkers for diagnosing and monitoring disease. This final practice puts you in the role of a researcher tasked with analyzing hypothetical gene expression data to find a diagnostic marker. You will apply a quantitative criterion to evaluate and rank candidate genes, gaining insight into the statistical principles that separate a good biomarker from a poor one [@problem_id:1470011].", "id": "1470011", "problem": "You are a junior researcher in a systems biology lab investigating a novel neurodegenerative disorder, termed Neurodegenerative Proteinopathy X (NP-X). A key goal is to identify a reliable, single-gene blood-based biomarker for early diagnosis. Your team has collected transcriptomic data from blood samples of 8 healthy control individuals and 8 patients definitively diagnosed with NP-X. You are tasked with analyzing the expression levels of five promising candidate genes.\n\nThe expression levels, measured in Fragments Per Kilobase of transcript per Million mapped reads (FPKM), are provided below:\n\n**Gene A: PROT1**\n- Healthy Controls: 10, 12, 11, 13, 9, 10, 14, 11\n- NP-X Patients: 25, 28, 26, 22, 30, 24, 27, 29\n\n**Gene B: FOLDASE2**\n- Healthy Controls: 5.1, 5.3, 4.9, 5.0, 5.2, 4.8, 5.4, 5.1\n- NP-X Patients: 8.2, 8.0, 8.5, 8.3, 8.1, 8.4, 8.6, 8.3\n\n**Gene C: METABX**\n- Healthy Controls: 101, 105, 98, 102, 100, 103, 99, 104\n- NP-X Patients: 103, 106, 100, 105, 101, 104, 102, 107\n\n**Gene D: SYNAP**\n- Healthy Controls: 50, 48, 52, 55, 47, 51, 53, 49\n- NP-X Patients: 40, 42, 38, 45, 39, 41, 43, 37\n\n**Gene E: CLEAR-A**\n- Healthy Controls: 20, 30, 15, 40, 25, 35, 18, 28\n- NP-X Patients: 30, 40, 25, 50, 35, 45, 28, 38\n\nTo quantitatively evaluate and compare the diagnostic potential of each gene, you must calculate a \"Biomarker Potential Score\" (BPS). The BPS for a given gene is defined as the absolute difference between the mean expression in the patient and control groups, normalized by the sum of their standard deviations. The formula is:\n$$ \\text{BPS} = \\frac{|\\mu_{\\text{patient}} - \\mu_{\\text{control}}|}{\\sigma_{\\text{patient}} + \\sigma_{\\text{control}}} $$\nwhere $\\mu$ is the sample mean and $\\sigma$ is the unbiased sample standard deviation. For a dataset $\\{x_1, x_2, \\dots, x_N\\}$ with $N$ data points, the sample mean is $\\mu = \\frac{1}{N} \\sum_{i=1}^{N} x_i$ and the unbiased sample standard deviation is $\\sigma = \\sqrt{\\frac{1}{N-1} \\sum_{i=1}^{N} (x_i - \\mu)^2}$.\n\nBased on your calculations, which of the following genes shows the most promise as a diagnostic biomarker for NP-X by having the highest BPS?\n\nA. PROT1\nB. FOLDASE2\nC. METABX\nD. SYNAP\nE. CLEAR-A\n\n", "solution": "We are given, for each gene, two independent samples (healthy controls and NP-X patients) with $N=8$ for each group. For each group we compute the sample mean $\\mu=\\frac{1}{N}\\sum_{i=1}^{N}x_{i}$ and the unbiased sample standard deviation $\\sigma=\\sqrt{\\frac{1}{N-1}\\sum_{i=1}^{N}(x_{i}-\\mu)^{2}}$. The Biomarker Potential Score (BPS) for each gene is then\n$$\n\\text{BPS}=\\frac{|\\mu_{\\text{patient}}-\\mu_{\\text{control}}|}{\\sigma_{\\text{patient}}+\\sigma_{\\text{control}}}.\n$$\n\nGene A: PROT1. Controls: $10,12,11,13,9,10,14,11$.\nCompute mean: $\\mu_{\\text{C}}=\\frac{10+12+11+13+9+10+14+11}{8}=\\frac{90}{8}=11.25$.\nDeviations and squares relative to $11.25$: $(-1.25)^{2}=1.5625$, $0.75^{2}=0.5625$, $(-0.25)^{2}=0.0625$, $1.75^{2}=3.0625$, $(-2.25)^{2}=5.0625$, $(-1.25)^{2}=1.5625$, $2.75^{2}=7.5625$, $(-0.25)^{2}=0.0625$. Sum of squares $=19.5$. Variance $=\\frac{19.5}{7}=\\frac{39}{14}$, so $\\sigma_{\\text{C}}=\\sqrt{\\frac{39}{14}}$.\nPatients: $25,28,26,22,30,24,27,29$.\nMean: $\\mu_{\\text{P}}=\\frac{211}{8}=26.375$.\nDeviations and squares relative to $26.375$: $(-1.375)^{2}=1.890625$, $1.625^{2}=2.640625$, $(-0.375)^{2}=0.140625$, $(-4.375)^{2}=19.140625$, $3.625^{2}=13.140625$, $(-2.375)^{2}=5.640625$, $0.625^{2}=0.390625$, $2.625^{2}=6.890625$. Sum $=49.875$. Variance $=\\frac{49.875}{7}=7.125$, so $\\sigma_{\\text{P}}=\\sqrt{7.125}$.\nDifference of means: $|\\mu_{\\text{P}}-\\mu_{\\text{C}}|=|26.375-11.25|=15.125$. Sum of standard deviations: $\\sigma_{\\text{P}}+\\sigma_{\\text{C}}=\\sqrt{7.125}+\\sqrt{\\frac{39}{14}}$. Hence\n$$\n\\text{BPS}_{A}=\\frac{15.125}{\\sqrt{7.125}+\\sqrt{\\frac{39}{14}}}\\approx \\frac{15.125}{2.6693+1.6697}\\approx \\frac{15.125}{4.3390}\\approx 3.485.\n$$\n\nGene B: FOLDASE2. Controls: $5.1,5.3,4.9,5.0,5.2,4.8,5.4,5.1$.\nMean: $\\mu_{\\text{C}}=\\frac{40.8}{8}=5.1$.\nDeviations relative to $5.1$: $0,0.2,-0.2,-0.1,0.1,-0.3,0.3,0$ with squares $0,0.04,0.04,0.01,0.01,0.09,0.09,0$, sum $=0.28$. Variance $=\\frac{0.28}{7}=0.04$, so $\\sigma_{\\text{C}}=0.2$.\nPatients: $8.2,8.0,8.5,8.3,8.1,8.4,8.6,8.3$.\nMean: $\\mu_{\\text{P}}=\\frac{66.4}{8}=8.3$.\nDeviations relative to $8.3$: $-0.1,-0.3,0.2,0,-0.2,0.1,0.3,0$ with squares $0.01,0.09,0.04,0,0.04,0.01,0.09,0$, sum $=0.28$. Variance $=\\frac{0.28}{7}=0.04$, so $\\sigma_{\\text{P}}=0.2$.\nDifference of means: $|\\mu_{\\text{P}}-\\mu_{\\text{C}}|=|8.3-5.1|=3.2$. Sum of standard deviations: $0.2+0.2=0.4$. Hence\n$$\n\\text{BPS}_{B}=\\frac{3.2}{0.4}=8.\n$$\n\nGene C: METABX. Controls: $101,105,98,102,100,103,99,104$.\nMean: $\\mu_{\\text{C}}=\\frac{812}{8}=101.5$.\nDeviations relative to $101.5$: $-0.5,3.5,-3.5,0.5,-1.5,1.5,-2.5,2.5$ with squares $0.25,12.25,12.25,0.25,2.25,2.25,6.25,6.25$, sum $=42$. Variance $=\\frac{42}{7}=6$, so $\\sigma_{\\text{C}}=\\sqrt{6}$.\nPatients: $103,106,100,105,101,104,102,107$.\nMean: $\\mu_{\\text{P}}=\\frac{828}{8}=103.5$.\nDeviations relative to $103.5$: $-0.5,2.5,-3.5,1.5,-2.5,0.5,-1.5,3.5$ with squares summing to $42$. Variance $=\\frac{42}{7}=6$, so $\\sigma_{\\text{P}}=\\sqrt{6}$.\nDifference of means: $|\\mu_{\\text{P}}-\\mu_{\\text{C}}|=|103.5-101.5|=2$. Sum of standard deviations: $2\\sqrt{6}$. Hence\n$$\n\\text{BPS}_{C}=\\frac{2}{2\\sqrt{6}}=\\frac{1}{\\sqrt{6}}\\approx 0.408.\n$$\n\nGene D: SYNAP. Controls: $50,48,52,55,47,51,53,49$.\nMean: $\\mu_{\\text{C}}=\\frac{405}{8}=50.625$.\nDeviations relative to $50.625$: $-0.625,-2.625,1.375,4.375,-3.625,0.375,2.375,-1.625$ with squares $0.390625,6.890625,1.890625,19.140625,13.140625,0.140625,5.640625,2.640625$, sum $=49.875$. Variance $=\\frac{49.875}{7}=7.125$, so $\\sigma_{\\text{C}}=\\sqrt{7.125}$.\nPatients: $40,42,38,45,39,41,43,37$.\nMean: $\\mu_{\\text{P}}=\\frac{325}{8}=40.625$.\nDeviations relative to $40.625$: $-0.625,1.375,-2.625,4.375,-1.625,0.375,2.375,-3.625$ with squares summing to $49.875$. Variance $=\\frac{49.875}{7}=7.125$, so $\\sigma_{\\text{P}}=\\sqrt{7.125}$.\nDifference of means: $|\\mu_{\\text{P}}-\\mu_{\\text{C}}|=|40.625-50.625|=10$. Sum of standard deviations: $2\\sqrt{7.125}$. Hence\n$$\n\\text{BPS}_{D}=\\frac{10}{2\\sqrt{7.125}}\\approx \\frac{10}{2\\cdot 2.6693}\\approx \\frac{10}{5.3386}\\approx 1.873.\n$$\n\nGene E: CLEAR-A. Controls: $20,30,15,40,25,35,18,28$.\nMean: $\\mu_{\\text{C}}=\\frac{211}{8}=26.375$.\nDeviations relative to $26.375$: $-6.375,3.625,-11.375,13.625,-1.375,8.625,-8.375,1.625$ with squares $40.640625,13.140625,129.640625,185.640625,1.890625,74.390625,70.140625,2.640625$, sum $=518.125$. Variance $=\\frac{518.125}{7}=74.0178571428571$, so $\\sigma_{\\text{C}}=\\sqrt{74.0178571428571}$.\nPatients: $30,40,25,50,35,45,28,38$.\nMean: $\\mu_{\\text{P}}=\\frac{291}{8}=36.375$.\nDeviations relative to $36.375$: $-6.375,3.625,-11.375,13.625,-1.375,8.625,-8.375,1.625$ have the same squares as controls; sum $=518.125$. Variance $=\\frac{518.125}{7}=74.0178571428571$, so $\\sigma_{\\text{P}}=\\sqrt{74.0178571428571}$.\nDifference of means: $|\\mu_{\\text{P}}-\\mu_{\\text{C}}|=|36.375-26.375|=10$. Sum of standard deviations: $2\\sqrt{74.0178571428571}$. Hence\n$$\n\\text{BPS}_{E}=\\frac{10}{2\\sqrt{74.0178571428571}}\\approx \\frac{10}{2\\cdot 8.6034}\\approx \\frac{10}{17.2068}\\approx 0.581.\n$$\n\nComparing the BPS values, we have approximately $\\text{BPS}_{A}\\approx 3.485$, $\\text{BPS}_{B}=8$, $\\text{BPS}_{C}\\approx 0.408$, $\\text{BPS}_{D}\\approx 1.873$, $\\text{BPS}_{E}\\approx 0.581$. The largest BPS is for FOLDASE2.", "answer": "$$\\boxed{B}$$"}]}